Stock Price
4.31
Daily Change
-0.13 -3.01%
Monthly
10.99%
Yearly
68.22%
Q1 Forecast
4.10

Acasti Pharma reported $0 in Cost of Sales for its fiscal quarter ending in March of 2022.





Cost Of Sales Change Date
Addus HomeCare USD 253.62M 3.63M Dec/2025
Amarin USD 26.05M 1.41M Dec/2025
Cassava Sciences USD 3.96M 1.16M Sep/2025
Knight Therapeutics CAD 82.22M 1.03M Dec/2025
Option Care Health USD 1.2B 23.4M Dec/2025
Organigram Holdings CAD 77.46M 14.63M Sep/2025
Tilray USD 164.37M 8.41M Sep/2025